Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream

NCT02918617 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

OTHER

Sponsor class

Conditions

Dentin Sensitivity

Interventions

DRUG: Control toothpaste containing Novamin® technology
DRUG: Control toothpaste containing 1500 ppm fluoride as MFP
DRUG: Test toothpaste with nano-HAP (high concentration)
DRUG: Test toothpaste with nano-HAP (low concentration)
DRUG: Test toothpaste with nano-HAP and (Potassium Nitrate) KNO3
DRUG: Control toothpaste without nano-HAP
DRUG: Test toothpaste with nano-HAP (medium concentration)
DRUG: Test cream with nano-HAP (higher concentration)
DRUG: Control cream without nano-HAP

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]